NGVT
NGVT
NYSE · Chemicals

Ingevity Corp

$73.41
+0.30 (+0.41%)
As of Aug 3, 9:56 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.17B
Net Income
-167,767,591
Gross Margin
39.5%
Profit Margin
-14.3%
Rev Growth
-11.2%
D/E Ratio
40.69
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.5% 39.5% 54.7% 54.7%
Operating Margin -12.2% -11.0% 9.7% 8.4%
Profit Margin -14.3% -13.6% 8.3% 7.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.17B 1.32B 1.58B 1.41B
Gross Profit 463.40M 521.90M 864.01M 770.79M
Operating Income -142,665,397 -144,609,592 152.89M 118.22M
Net Income -167,767,591 -170,053,870 130.65M 101.13M
Gross Margin 39.5% 39.5% 54.7% 54.7%
Operating Margin -12.2% -11.0% 9.7% 8.4%
Profit Margin -14.3% -13.6% 8.3% 7.2%
Rev Growth -11.2% -11.2% +17.8% +22.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.25B 1.25B 220.13M 210.25M
Total Equity 30.61M 30.61M 1.03B 929.02M
D/E Ratio 40.69 40.69 0.21 0.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -110,340,685 -118,057,946 192.21M 179.91M
Free Cash Flow 123.30M 118.87M